Skip to content

APOTHEEK BOUAKKA

Active
Private limited companyfounded 2011active for 15 yearsLange Van Bloerstraat 88, 2060 Antwerpen, BelgiumKBO/BCE: BE 0837.524.724

From the official registers: KBO 14 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

APOTHEEK BOUAKKA has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €282,809 and a net result of €48,582. Equity has been stable since 2018 (±0.6% per year). Its solvency ranks better than 82% of 22,726 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

KBO
Status
Active since 30-06-2011 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.202.276.419 2060 Antwerpen, since 01-07-2011
Financial year end
31 December
Peppol
Reachable since 24-11-2023

Board and ownership

Board

Financial position

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€167,787
▲ 21.8%
Turnover
≈ €530,000
estimated
Profit
€48,582
▲ 65.1%
Equity
€282,809
▲ 5.8%
Total assets
€394,063
▲ 20.1%
Staff
1 FTE
=
Filed on 13-08-2026, 13 days after the deadlineat the National Bank
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 3.86, cash €116,681Equity €282,809 (71.8% of total assets)Founded in 2011Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 71% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Strong
Solvency 97-3
equity 71.8% of total assets
Liquidity 77-9
short-term debt 25.8% · cash 29.6%
Profitability 78+11
return on assets 12.3%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.2%▲ +0.1 percentage points vs 07-2025highest value 09-2025: 0.1%▼ -0.1 percentage points vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025lowest value 02-2026: 0.1%● unchanged vs 01-2026lowest value 03-2026: 0.1%● unchanged vs 02-2026lowest value 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.2%▲ +0.1 percentage points vs 07-2026 09-2026: 0.1%▼ -0.1 percentage points vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.86 (6.2 in 2024), above the usual 1.5. Short-term debt is 25.8% and cash 29.6% of total assets. 28.2% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 82% of them on solvency, 82% on liquidity, 68% on profitability and 53% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises risk
lowers risk · Liquidity: current ratio 3.86, cash €116,681
NBB · annual accounts
lowers risk · Equity €282,809 (71.8% of total assets)
NBB · annual accounts
lowers risk · Founded in 2011
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €282,809
raises risk · 2025 accounts filed 13 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-08-2026, 13 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
13 days late
2024
on the day
2023
1 day early
2022
17 days late
2021
19 days late
2020
9 days late
2019
10 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 10 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 13 August (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: More equity than 90% of companies in retail tradesector median €41,216 · 22,767 companies €282,809 View
  • Positive: 6 profitable years in a rowprofit 2025: €48,582 6 years View

Comparable companies

These companies have the same main activity as APOTHEEK BOUAKKA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €369,000 and €430,000, founded between 2009 and 2011.

CompanyTotal assetsGross margin
APOTHEEK BOUAKKA Antwerpen€394,063€167,787
LA ROUE PHARMA Anderlecht€369,361€161,702
KOLTFARMA Charleroi€381,713€179,770
PHARMACIE MULLER Visé€430,209€158,883
Apotheek Demapharm Grimbergen€408,920€149,312
APOTHEEK OPHASSELT Geraardsbergen€422,127€153,135
APOTHEEK SCHOOFS KRISTIE Oudsbergen€412,440€160,039
Full comparison

Documents

Annual accounts at the NBB

All 14 annual accounts

Articles and registers

Key facts about APOTHEEK BOUAKKA

What is the company number of APOTHEEK BOUAKKA?
The company number of APOTHEEK BOUAKKA is 0837.524.724. The VAT number is the same number with BE in front: BE 0837.524.724.
Where is APOTHEEK BOUAKKA based?
The registered office is at Lange Van Bloerstraat 88, 2060 Antwerpen.Company details
What does APOTHEEK BOUAKKA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK BOUAKKA?
The legal form of APOTHEEK BOUAKKA is Private limited company (BV).
When was APOTHEEK BOUAKKA founded?
APOTHEEK BOUAKKA was founded on 30-06-2011.
Is APOTHEEK BOUAKKA still active?
Yes, APOTHEEK BOUAKKA is an active enterprise in the KBO register.
How many employees does APOTHEEK BOUAKKA have?
APOTHEEK BOUAKKA had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK BOUAKKA?
The turnover in financial year 2025 is ≈ €530,000. This figure is estimated from the gross margin of €167,787 and 32 comparable companies (NACE 477). It probably lies between €370,000 and €1.0m.
Is APOTHEEK BOUAKKA profitable?
In financial year 2025, APOTHEEK BOUAKKA made a profit of €48,582.
Where can I find the annual accounts of APOTHEEK BOUAKKA?
APOTHEEK BOUAKKA filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of APOTHEEK BOUAKKA due?
APOTHEEK BOUAKKA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.